Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 14, 2009; 15(6): 648-674
Published online Feb 14, 2009. doi: 10.3748/wjg.15.648
Published online Feb 14, 2009. doi: 10.3748/wjg.15.648
Incidence at 5 yr (%) | Risk factors | |
Acute rejection | Variable (< 30) | Inadequate immunosuppression |
Treatment with immune activating drugs (e.g. interferon) | ||
History of autoimmune liver disease | ||
Chronic rejection | -3 | Inadequate immunosuppression |
Treatment with immune-activating drugs (e.g. interferon) | ||
Refractory acute rejection | ||
Chronic rejection in a previous failed allograft | ||
Recurrent AIH | -30 | Suboptimal immunosuppression |
AIH type I | ||
Severe inflammation in native liver | ||
HLA DR3 or DR4 | ||
De novo AIH | < 5 | |
Recurrent PBC | 20-30 | Tacrolimus as baseline immunosuppression |
Living-related donor | ||
Steroid and other immunosuppression withdrawal | ||
Recurrent PSC | 20-30 | Male sex; donor-recipient gender mismatch |
Intact colon at time of transplantation | ||
Idiopathic post-transplant hepatitis | 5-60 |
- Citation: Spada M, Riva S, Maggiore G, Cintorino D, Gridelli B. Pediatric liver transplantation. World J Gastroenterol 2009; 15(6): 648-674
- URL: https://www.wjgnet.com/1007-9327/full/v15/i6/648.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.648